FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA Approved Medications For March 2026 Guideline Central The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK Cu Wholesale Pricing Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn